Invest In Retrieve Medical
Revolutionizing The Future of Healthcare Documentation
Retrieve Medical, a publicly traded company, symbol (RMHI), has a mission to redefine healthcare documentation through the innovative application of AI technology. We are poised to dramatically enhance efficiency and precision in medical record-keeping through more concise and complete medical documentation in hospitals and medical centers.
SIGN UP FOR UPDATES
Compatibility with Industry Leaders
Multi Billion Dollar Opportunity in the Future of Healthcare1
Retrieve Medical has 3 key revenue sources in its Software as a Service (SaaS) model: One revenue source is the SaaS product that costs hospitals a nominal charge of $25 per patient admission for utilizing its software. Another revenue source is ACOs (Accountable Care Organizations). In addition to those two revenue sources, they also have ambulatory care. With an estimated 34 million hospital admissions annually the revenue potential for Retrieve Medical amounts to a significant multi-billion dollar opportunity.
Retrieve's Profit Potential
Retrieve searches through patient records picking up all patient data that resides on databases and files throughout the hospital or medical center as well as noting any comorbidities that may present themselves. Using the Software as a Service (SaaS) model, the potential return on investment (ROI) typically exceeds 10:1, impacting both healthcare efficiency and financial performance2.
Our Exciting Growth Trajectory
As past President of The American College of Emergency Physicians, our Chairman, Dr. Rosenberg has extensive connections with leading physician groups across the USA, allowing us to take a multi-faceted approach to growth. This includes direct marketing to hospitals and active participation in industry events.
Download the
Retrieve investor deck
Revolutionizing Healthcare Documentation with AI Mastery3
Our AI engine delves deep into every patient's information, identifying essential health details to create the optimal healthcare experience for both patients and their providers. Documenting information (such as comorbidities) that would otherwise not be mentioned enables hospitals to code patients with a more complete diagnosis. This improves patient outcomes and increases reimbursement levels. In addition, our software is compatible with all major Electronic Medical Record Applications.
Exclusive Investor Perks
Invest and be eligible to receive exclusive perks:
Bonus Tier 1
Bonus Shares
When you invest $5,000+
Bonus Tier 2
Bonus Shares
When you invest $10,000+
Bonus Tier 3
Bonus Shares
When you invest $25,000+
A Team with a Winning Track Record
Founded by seasoned medical professionals, and entrepreneurs with a track record in commercializing groundbreaking technologies and orchestrating successful exits for companies, we have been fueled by a fervor for pioneering healthcare solutions. Retrieve Medical represents the apex of this dedication, providing a unique opportunity to leave a lasting imprint on the documentation and delivery of healthcare services.
Mark Rosenberg, DO, MBA, FACEP is an emergency physician with over 45 years of experience in healthcare. Dr. Rosenberg is well known as an innovator and problem solver throughout his career as a clinician, administrator, business owner, and consultant. As President of the American College of Emergency Physicians, Dr. Rosenberg’s collaboration with esteemed colleagues nationally and abroad provided a framework for its 40,000 physician members to address the pandemic. Dr. Rosenberg serves as Chairman of the Board for Retrieve Medical since 2019.
Jerry has worked with experts from academic environments including Princeton, Cornell, Rutgers, University of Louisville, and the National Basketball Association commercializing technologies. He has been CEO of four public companies and orchestrated exit strategies for five companies with a total market cap of $300M+.
Dr Thomas has created or reshaped clinical care delivery systems in 30+ healthcare organizations in the northern hemisphere. He graduated from Howard University College of Medicine with an M.D. in Medicine and earned his A.B. in Physical Science and Genetics at Harvard University.
.png)
Joerg’s career encompasses a broad range of appointments in corporate financial management, controllership and administrative functions in a variety of business environments including publicly held companies. He graduated from the Banking School in Berlin, Germany, and holds a master’s degree in business administration from Rutgers University.
Updates
Retrieve Medical Study Release
March 22, 2024 - Bedminster, NJ -- Retrieve Medical Holdings, Inc. (RMHI), the developer of Retrieve Dx, a real-time, cloud-based CDI (Clinical Documentation Integrity) application that improves physician documentation, today announced a study showing a substantial increase in documented diagnoses using the Retrieve software. In this updated study, 10,542 charts were analyzed, and 12,506 additional comorbidities and diagnoses were identified using the Retrieve Dx software solution.
Read MoreFAQs
Regulation CF allows investors to invest in startups and early-growth companies. This is different from helping a company raise money on Kickstarter; with Regulation CF Offerings, you aren’t buying products or merchandise - you are buying a piece of a company and helping it grow.
Accredited investors can invest as much as they want. But if you are NOT an accredited investor, your investment limit depends on either your annual income or net worth, whichever is greater. If the number is less than $124,000, you can only invest 5% of it. If both are greater than $124,000 then your investment limit is 10%.
To calculate your net worth, just add up all of your assets and subtract all of your liabilities (excluding the value of the person’s primary residence). The resulting sum is your net worth.
We cannot give tax advice, and we encourage you to talk with your accountant or tax advisor before making an investment.
Individuals over 18 years of age can invest.
There will always be some risk involved when investing in a startup or small business. And the earlier you get in the more risk that is usually present. If a young company goes out of business, your ownership interest could lose all value. You may have limited voting power to direct the company due to dilution over time. You may also have to wait about five to seven years (if ever) for an exit via acquisition, IPO, etc. Because early-stage companies are still in the process of perfecting their products, services, and business model, nothing is guaranteed. That’s why startups should only be part of a more balanced, overall investment portfolio.
The Common Stock (the "Shares") of Retrieve Medical (OTCMKTS: RMHI) (the "Company") are publicly-traded. As a result, subject to satisfaction of applicable securities regulations (including applicable holding periods), holders of Shares may engage in public resales transactions.
Shares sold via Regulation Crowdfunding offerings have a one-year lockup period before those shares can be sold under certain conditions.
Exceptions to limitations on selling shares during the one-year lockup period:
In the event of death, divorce, or similar circumstance, shares can be transferred to:
• The company that issued the securities
• An accredited investor
• A family member (child, stepchild, grandchild, parent, stepparent, grandparent, spouse or equivalent, sibling, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law, including adoptive relationships)
If a company does not reach their minimum funding target, all funds will be returned to the investors after the close of the offering.
All available disclosure information can be found on the offering pages for our Regulation Crowdfunding offering.
You can cancel your investment at any time, for any reason, until 48 hours prior to a closing occurring. If you’ve already funded your investment and your funds are in escrow, your funds will be promptly refunded to you upon cancellation. To submit a request to cancel your investment please email: ir@retrievemedical.com
At a minimum, the company will be filing with the SEC and posting on its website an annual report, along with certified financial statements. Those should be available 120 days after the fiscal year end. If the company meets a reporting exception, or eventually has to file more reported information to the SEC, the reporting described above may end. If these reports end, you may not continually have current financial information about the company.
Once an offering ends, the company may continue its relationship with DealMaker Securities for additional offerings in the future. DealMaker Securities’ affiliates may also provide ongoing services to the company. There is no guarantee any services will continue after the offering ends.
$1.50
The minimum investment size for this current round is $1,000.
Common
Approx $5 million
Investing in Retrieve Medical is an attractive opportunity for several reasons. First, they solve a compelling problem that improves patient outcomes, makes physicians’ lives easier, and improves hospital reimbursements. The demand is clear. The company's recurring revenue model, based on a Software as a Service (SaaS) structure, ensures a steady and predictable income stream through regular billing. We know the tech works well because Retrieve Medical has already shown proven results in improving hospital reimbursements and operational efficiencies. And we know they can scale this solution because of their strategic relationships with major healthcare systems and vendors underscore a strong market presence and potential for further growth. The company is at the cutting edge of healthcare technology, employing AI and natural language processing, appealing to investors interested in innovative and future-focused businesses. Finally, as the healthcare sector continues to expand and evolve, especially with a focus on technology and efficiency, Retrieve Medical is well-positioned to benefit from these trends, offering investors a chance to be part of a company that's not just profitable but also pivotal in enhancing healthcare operations and patient outcomes.
The model operates on a Software-as-a-service (SaaS) basis, meaning hospitals pay a recurring fee for using Retrieve Medical's software. They charge hospitals $25 for each patient admitted, but this cost is offset by the significant increase in reimbursements hospitals receive due to improved documentation quality. Essentially, hospitals pay a small fee upfront but stand to gain much more in return. The return on investment (ROI) for hospitals using Retrieve Medical's services is projected to be between 6X and 25X.
It’s a “no-brainer” for hospitals if it speeds up operations, makes physicians' jobs easier, improves patient outcomes, and improves hospital reimbursement. They’ve already shown this technology can deliver those results.
They are just getting started so this is a true ground-floor opportunity.
Electronic documentation is already a big business (Epic does $4.6B in sales each year4). What makes this solution a new opportunity is it was built by the people who actually have to use electronic documentation systems, so they have firsthand experience of what the problems are and how to fix them in a way that works.
Working capital, additional software development, sales and marketing.
Bonus shares.
Investing in startups is risky and there is no guarantee you will get a return on your investment. However, an exit opens up the opportunity where you could convert your shares into cash or a more liquid asset. Exits include going public, getting acquired by a larger company, or our company buying back shares. If the value of our company grows, then you have a higher potential of making a profit on your investment during one of these exits.
If we are able to raise the full amount it is anticipated that this will allow us to get our product to market. We would expect to need additional capital at that time to market and sell the product.
Shares will be rewarded after the investment funds clear. This typically takes around 3 weeks after investment
No, costs are the same, regardless of how you invest.
No.
JOIN THE DISCUSSION